Abstract:Background Alcohol withdrawal‐induced hyperalgesia (AWH) is characterized as an increased pain sensitivity observed after cessation of chronic alcohol use. Alcohol withdrawal‐induced hyperalgesia can contribute to the negative affective state associated with abstinence and can increase susceptibility to relapse. We aimed to characterize pain sensitivity in mice during withdrawal from two different models of alcohol exposure: chronic drinking in the dark (DID) and the Lieber–DeCarli liquid diet. We also investigated whether treatment with a histone deacetylase (HDAC) inhibitor, suberoylanilide hydroxamic acid (SAHA), could ameliorate AWH in mice treated with the Lieber–DeCarli diet. Methods Male and female C57BL/6J mice were used for these studies. In the DID model, mice received bottles of 20% ethanol or water during the dark cycle for 4 h per day on four consecutive days per week for 6 weeks. Peripheral mechanical sensitivity was measured weekly the morning of Day 5 using von Frey filaments. In the Lieber–DeCarli model, mice received ethanol (5% v/v) or control liquid diet for 10 days, along with a single binge ethanol gavage (5 g/kg) or control gavage, respectively, on Day 10. Peripheral mechanical sensitivity was measured during the liquid diet administration and at 24 and 72 h into ethanol withdrawal. An independent group of mice that received the Lieber–DeCarli diet were administered SAHA (50 mg/kg, i.p.) during withdrawal. Results Male mice exhibited mechanical hypersensitivity after consuming ethanol for 5 weeks in the DID procedure. In the Lieber–DeCarli model, ethanol withdrawal led to hyperalgesia in both sexes. Suberoylanilide hydroxamic acid treatment during withdrawal from the ethanol liquid diet alleviated AWH. Conclusions These results demonstrate AWH in mice after chronic binge drinking in males and after Lieber–DeCarli liquid diet administration in both sexes. Like previous findings in rats, HDAC inhibition reduced AWH in mice, suggesting that epigenetic mechanisms are involved in AWH.

The effects of D-histiding on the expression of morphine tolerance and physical dependence in mice

Morphine Epigenomically Regulates Behavior Through Alterations in Histone H3 Lysine 9 Dimethylation in the Nucleus Accumbens

Ameliorating Effect of Histamine on Impairment of Cued Fear Extinction Induced by Morphine Withdrawal in Histidine Decarboxylase Gene Knockout Mice

Endogenous histamine inhibits the development of morphine-induced conditioned place preference

Morphine induces conditioned place preference behavior in histidine decarboxylase knockout mice.

The Effect of Dihydromyricetin, a Natural Flavonoid, on Morphine-induced Conditioned Place Preference and Physical Dependence in Mice

Effect of the histone deacetylase inhibitors on behavioural sensitization to a single morphine exposure in mice.

Effect of Morphine Dependence and Abstinence on the Expression of B-cell Lymphomal-2 in Sprague-Dawley Rats

INHIBITORY EFFECT OF DILTIAZEM ON MORPHINE WITHDRAWAL SYNDROMES AND THE LEVELS OF NO IN PLASMA AND BRAIN HOMOGENATE IN MORPHINE DEPENDENT MICE

Effect of Morphine Dependence on the Ultrastructure of Sprague-Dawley Rats

Immunosuppressive Effects of Dihydroetorphine, a Potent Narcotic Analgesic, in Dihydroetorphine-Dependent Mice.

The Effect of Morphine Upon DNA Methylation in Ten Regions of the Rat Brain

Identification of A Novel Spinal Dorsal Horn Astroglial D-Amino Acid Oxidase-Hydrogen Peroxide Pathway Involved in Morphine Antinociceptive Tolerance

Morphine and Heroin Differentially Modulate in Vivo Hippocampal LTP in Opiate-Dependent Rat

Inhibition of Histone Deacetylases Attenuates Morphine Tolerance and Restores MOR Expression in the DRG of BCP Rats

Histone deacetylase inhibitor decreases hyperalgesia in a mouse model of alcohol withdrawal‐induced hyperalgesia

Blockade of Neuronal Dopamine D2 Receptor Attenuates Morphine Tolerance in Mice Spinal Cord

Dopamine D3 Receptor Knock-out Mice Display Deficits in Locomotor Sensitization after Chronic Morphine Administration.

Suppressing High Mobility Group Box-1 Release Alleviates Morphine Tolerance Via the Adenosine 5'-Monophosphate-activated Protein Kinase/heme Oxygenase-1 Pathway.

Effects of 5-HT1A Receptor Antagonist and 5-HT2A Receptor Agonist on Morphine Withdrawal

Involvement of Μ-Opioid Receptors and Α-Adrenoceptors in the Immunomodulatory Effects of Dihydroetorphine